B. Hancock

Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.

T. Lister, A. Horwich, J. Radford, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

T. Lister, A. Horwich, R. Gupta, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.

Anthony J. Swerdlow, David C. Linch, Alan Horwich, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma.

D. Dunlop, C. Fegan, D. Cunningham, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial

K. Maclennan, W. Gregory, D. Linch, 2001, British Journal of Cancer.

Primary bone lymphoma: a retrospective analysis.

R. Hough, B. Hancock, J. Thomas, 2006, International journal of oncology.

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

M. Williams, T. Lister, A. Horwich, 2013, British Journal of Cancer.

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

K. Maclennan, W. Gregory, P. Hoskin, 2001, Blood.

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma

K. Maclennan, P. Hoskin, D. Linch, 2004, British Journal of Cancer.